Company intelligence
Lucida Medical
Advancing the prostate cancer pathway with AI to support physicians, reduce costs, and deliver better care.
Medical Device
Cambridge, GB
34 employees
Founded 2020
4 public signals
About Lucida Medical
Lucida Medical develops software tools using AI and MRI, to support cancer screening, diagnosis and management. Pi™ is a CE-marked medical device intended to help doctors find prostate cancer, the most common cancer in men, with outstanding clinical data, automation and workflow integration.
Verified activity
Signals from Lucida Medical
4 published signals
Presence & Recognition
Lucida Medical CEO and Co-founder Dr Antony Rix will discuss how AI can change pathways in prostate cancer at the All-Ireland Clinical AI Congress & AI Tech Expo on 12 September at O'Reilly Hall, UCD Dublin.
Reported by Lucida Medical
Presence & Recognition
Lucida Medical is presenting findings on AI for prostate cancer diagnosis at ESUR, Europe's leading conference on urogenital radiology.
Reported by Antony Rix
Presence & Recognition
Lucida Medical is scheduled to meet clinicians, researchers, and partners across Europe in September.
Reported by Lucida Medical
Presence & Recognition
Lucida Medical is presenting at the first All-Ireland Clinical AI Congress & AI Tech Expo on 12 September at UCD to deliver faster and more accurate cancer diagnosis.
Reported by Antony Rix